Cargando…

Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy

BACKGROUND: Canada is facing an urgent challenge to reduce the harms associated with opioids: from January 2016 to December of 2018, more than 11,500 individuals lost their lives due to opioid related harms. This review examines responses to the opioid crisis thus far, the lessons learned from these...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Sheena, Maloney-Hall, Bridget, Buxton, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700784/
https://www.ncbi.nlm.nih.gov/pubmed/31426814
http://dx.doi.org/10.1186/s13011-019-0220-7
_version_ 1783444930197192704
author Taha, Sheena
Maloney-Hall, Bridget
Buxton, Jane
author_facet Taha, Sheena
Maloney-Hall, Bridget
Buxton, Jane
author_sort Taha, Sheena
collection PubMed
description BACKGROUND: Canada is facing an urgent challenge to reduce the harms associated with opioids: from January 2016 to December of 2018, more than 11,500 individuals lost their lives due to opioid related harms. This review examines responses to the opioid crisis thus far, the lessons learned from these initiatives and the knowledge gaps that still need to be addressed across the four pillar model adopted by the CDSS. METHODS: A search of peer-reviewed literature was conducted in PubMed and PsycNet, and grey literature was retrieved from reputable substance use and health organizations to determine responses to the opioid crisis and related outcomes between 2013 and 2019. Findings related to actions, outcomes and unintended consequences across the categories of prevention, treatment, harm reduction, enforcement and the evidence base were included and synthesized into a narrative review on lessons learned. RESULTS: The opioid crisis is a result of multiple, complex interrelated factors. Many physicians may not feel competent to appropriately treat pain and/or addiction. Pushes for opioid deprescribing have resulted in some individuals using illicit opioids as treatment. A range of effective and accessible pharmacological and psychological treatments are still required. When regulations are barriers, unsanctioned actions, such as overdose prevention sites, may be enacted by individuals to respond to urgent public health needs. A nimble response with evolving enforcement perspectives can aid individuals experiencing harms from opioid use. CONCLUSIONS: There is no one size fits all response to this crisis, and consideration should be given to the unique needs of different communities and populations, as well as the broader impact of harms on families, communities, and society. A situation so multifaceted requires both immediate and long-term strategies implemented concurrently in order to address the differing and on-going needs of Canadians experiencing opioid harms. The expertise of individuals and families affected by the opioid crisis must be included in consultations and decisions related to different strategies, to ensure responses are not stigmatizing, that they will be effective and acceptable and that unintended consequences are quickly recognized and mitigated.
format Online
Article
Text
id pubmed-6700784
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67007842019-08-26 Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy Taha, Sheena Maloney-Hall, Bridget Buxton, Jane Subst Abuse Treat Prev Policy Review BACKGROUND: Canada is facing an urgent challenge to reduce the harms associated with opioids: from January 2016 to December of 2018, more than 11,500 individuals lost their lives due to opioid related harms. This review examines responses to the opioid crisis thus far, the lessons learned from these initiatives and the knowledge gaps that still need to be addressed across the four pillar model adopted by the CDSS. METHODS: A search of peer-reviewed literature was conducted in PubMed and PsycNet, and grey literature was retrieved from reputable substance use and health organizations to determine responses to the opioid crisis and related outcomes between 2013 and 2019. Findings related to actions, outcomes and unintended consequences across the categories of prevention, treatment, harm reduction, enforcement and the evidence base were included and synthesized into a narrative review on lessons learned. RESULTS: The opioid crisis is a result of multiple, complex interrelated factors. Many physicians may not feel competent to appropriately treat pain and/or addiction. Pushes for opioid deprescribing have resulted in some individuals using illicit opioids as treatment. A range of effective and accessible pharmacological and psychological treatments are still required. When regulations are barriers, unsanctioned actions, such as overdose prevention sites, may be enacted by individuals to respond to urgent public health needs. A nimble response with evolving enforcement perspectives can aid individuals experiencing harms from opioid use. CONCLUSIONS: There is no one size fits all response to this crisis, and consideration should be given to the unique needs of different communities and populations, as well as the broader impact of harms on families, communities, and society. A situation so multifaceted requires both immediate and long-term strategies implemented concurrently in order to address the differing and on-going needs of Canadians experiencing opioid harms. The expertise of individuals and families affected by the opioid crisis must be included in consultations and decisions related to different strategies, to ensure responses are not stigmatizing, that they will be effective and acceptable and that unintended consequences are quickly recognized and mitigated. BioMed Central 2019-08-19 /pmc/articles/PMC6700784/ /pubmed/31426814 http://dx.doi.org/10.1186/s13011-019-0220-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Taha, Sheena
Maloney-Hall, Bridget
Buxton, Jane
Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title_full Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title_fullStr Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title_full_unstemmed Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title_short Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy
title_sort lessons learned from the opioid crisis across the pillars of the canadian drugs and substances strategy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700784/
https://www.ncbi.nlm.nih.gov/pubmed/31426814
http://dx.doi.org/10.1186/s13011-019-0220-7
work_keys_str_mv AT tahasheena lessonslearnedfromtheopioidcrisisacrossthepillarsofthecanadiandrugsandsubstancesstrategy
AT maloneyhallbridget lessonslearnedfromtheopioidcrisisacrossthepillarsofthecanadiandrugsandsubstancesstrategy
AT buxtonjane lessonslearnedfromtheopioidcrisisacrossthepillarsofthecanadiandrugsandsubstancesstrategy